Search research articles
Contact Us
Filters
Showing results (181-190 of 220) with videos related to
Page
of 22
Sort By:
Journal of the American Heart Association
|
August 20, 2019
Interaction of α Carboxyl Terminus 1 Peptide With the Connexin 43 Carboxyl Terminus Preserves Left Ventricular Function After Ischemia-Reperfusion Injury
Jingbo Jiang, Daniel Hoagland, Joseph A Palatinus, et al.
Blood
|
January 4, 2011
Induction of Ca²+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction
Fei Zhong, Michael W Harr, Geert Bultynck, et al.
Cell Death & Disease
|
September 8, 2023
Intracellular BAPTA directly inhibits PFKFB3, thereby impeding mTORC1-driven Mcl-1 translation and killing MCL-1-addicted cancer cells
Flore Sneyers, Martijn Kerkhofs, Femke Speelman-Rooms, et al.
The Journal of Biological Chemistry
|
December 1, 2011
The C terminus of Bax inhibitor-1 forms a Ca2+-permeable channel pore
Geert Bultynck, Santeri Kiviluoto, Nadine Henke, et al.
Cell Death Discovery
|
August 1, 2024
The endoplasmic reticulum pool of Bcl-xL prevents cell death through IP3R-dependent calcium release
Rudy Gadet, Lea Jabbour, Trang Thi Minh Nguyen, et al.
Cell Calcium
|
February 16, 2017
DPB162-AE, an inhibitor of store-operated Ca<sup>2+</sup> entry, can deplete the endoplasmic reticulum Ca<sup>2+</sup> store
Mart Bittremieux, Julia V Gerasimenko, Marleen Schuermans, et al.
Scientific Reports
|
April 16, 2015
Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domain
Tim Vervliet, Irma Lemmens, Elien Vandermarliere, et al.
Signal Transduction and Targeted Therapy
|
March 21, 2025
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
Meike Vogler, Yannick Braun, Victoria M Smith, et al.
Plos One
|
October 19, 2013
Alpha-helical destabilization of the Bcl-2-BH4-domain peptide abolishes its ability to inhibit the IP3 receptor
Giovanni Monaco, Elke Decrock, Koen Nuyts, et al.
Cell Death & Disease
|
August 20, 2020
MICAL2 is essential for myogenic lineage commitment
Nefele Giarratana, Filippo Conti, Rita La Rovere, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 220) with videos related to
Sort By:
Page
of 22
Journal of the American Heart Association
|
August 20, 2019
Interaction of α Carboxyl Terminus 1 Peptide With the Connexin 43 Carboxyl Terminus Preserves Left Ventricular Function After Ischemia-Reperfusion Injury
Jingbo Jiang, Daniel Hoagland, Joseph A Palatinus, et al.
Blood
|
January 4, 2011
Induction of Ca²+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction
Fei Zhong, Michael W Harr, Geert Bultynck, et al.
Cell Death & Disease
|
September 8, 2023
Intracellular BAPTA directly inhibits PFKFB3, thereby impeding mTORC1-driven Mcl-1 translation and killing MCL-1-addicted cancer cells
Flore Sneyers, Martijn Kerkhofs, Femke Speelman-Rooms, et al.
The Journal of Biological Chemistry
|
December 1, 2011
The C terminus of Bax inhibitor-1 forms a Ca2+-permeable channel pore
Geert Bultynck, Santeri Kiviluoto, Nadine Henke, et al.
Cell Death Discovery
|
August 1, 2024
The endoplasmic reticulum pool of Bcl-xL prevents cell death through IP3R-dependent calcium release
Rudy Gadet, Lea Jabbour, Trang Thi Minh Nguyen, et al.
Cell Calcium
|
February 16, 2017
DPB162-AE, an inhibitor of store-operated Ca<sup>2+</sup> entry, can deplete the endoplasmic reticulum Ca<sup>2+</sup> store
Mart Bittremieux, Julia V Gerasimenko, Marleen Schuermans, et al.
Scientific Reports
|
April 16, 2015
Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domain
Tim Vervliet, Irma Lemmens, Elien Vandermarliere, et al.
Signal Transduction and Targeted Therapy
|
March 21, 2025
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
Meike Vogler, Yannick Braun, Victoria M Smith, et al.
Plos One
|
October 19, 2013
Alpha-helical destabilization of the Bcl-2-BH4-domain peptide abolishes its ability to inhibit the IP3 receptor
Giovanni Monaco, Elke Decrock, Koen Nuyts, et al.
Cell Death & Disease
|
August 20, 2020
MICAL2 is essential for myogenic lineage commitment
Nefele Giarratana, Filippo Conti, Rita La Rovere, et al.
Page
of 22